Doximity
Digital networking platform for U.S. healthcare professionals
Website: https://www.doximity.com
Cover Block
PUBLIC
| Name | Doximity |
| Tagline | Digital networking platform for U.S. healthcare professionals |
| Headquarters | San Francisco, California |
| Founded | 2011 |
| Stage | Public |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | $10M+ (total disclosed ~$27,800,000) |
Links
PUBLIC
- Website: https://www.doximity.com
- LinkedIn: https://www.linkedin.com/company/doximity
Executive Summary
PUBLIC Doximity has established a defensible, high-margin business by digitizing the professional network for U.S. physicians, a wedge that has scaled into a comprehensive clinical productivity platform. The company's attention stems from its demonstrated ability to convert deep network penetration into recurring software revenue, with fiscal 2025 sales reaching $570.4 million on 20% year-over-year growth [Doximity Investors, 2025]. Founded in 2011 by Nate Gross, Jeff Tangney, and Shari Buck, the platform now claims verified membership from over 85% of U.S. doctors, creating significant switching costs and a durable audience for its SaaS tools [Doximity].
CEO Jeff Tangney brought prior experience from founding Epocrates, a point-of-care medical reference app, which provided early credibility in the healthcare vertical [Doximity]. The core product suite extends beyond professional networking to include telehealth, AI-powered clinical documentation, and secure care coordination, positioning Doximity as an operating system for medical practice rather than a simple directory [Doximity]. The company transitioned to public markets after raising a total of $27.8 million in venture capital from firms including Emergence Capital Partners and Morgenthaler Ventures [Wikipedia].
Over the next 12 to 18 months, the primary watchpoints are the monetization depth of its existing member base, the competitive response from larger health IT platforms, and the execution of its AI tooling roadmap as co-founder Nate Gross departed to lead healthcare initiatives at OpenAI [Bloomberg, Business Insider, Fortune, 2026]. The platform's growth will depend on expanding wallet share within its core physician segment while defending its network moat.
Data Accuracy: GREEN -- Core financials and headcount are sourced from SEC filings; market penetration claims are company-reported but widely cited.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Public |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $10M+ (total disclosed ~$27,800,000) |
Company Overview
PUBLIC
Doximity was founded in March 2011 by Nate Gross, Jeff Tangney, and Shari Buck as a professional networking service specifically for U.S. medical professionals [Wikipedia]. The company is headquartered in San Francisco, California, and operates as a public entity [Doximity]. Its founding wedge was to create a verified, secure digital hub for physicians and advanced practice providers, a market segment that was not fully served by general-purpose social networks.
A key early milestone was the closure of a $10.8 million Series A round in March 2011, led by Emergence Capital Partners and Interwest Partners [Wikipedia]. This was followed by a $17 million Series B in September 2012, led by Morgenthaler Ventures [Wikipedia]. The company achieved a significant scale milestone by going public, and as of its fiscal year ending March 31, 2025, it reported total revenues of $570.4 million, representing 20% year-over-year growth [Doximity Investors, 2025].
Data Accuracy: YELLOW -- Founding details and early funding are confirmed by Wikipedia, a public database. The revenue figure is a direct company disclosure, but other corporate milestones rely on a single source.
Product and Technology
MIXED
The core product is a closed, verified network for U.S. healthcare professionals, a design choice that underpins both its utility and its defensibility. Doximity describes its platform as a cloud-based hub for professional networking and clinical collaboration, bundling tools for curated medical news, telehealth, AI-powered documentation, clinical decision-support, and secure care coordination [Doximity]. This suite positions it less as a social network and more as a daily productivity operating system for clinicians, integrating workflow tools directly into the professional graph.
Network density is the primary technical asset, with the company claiming over 85% of U.S. doctors and 65% of all nurse practitioners and physician assistants as verified members [Doximity]. This penetration creates a high-utility environment for peer consultation and referral patterns that are difficult to replicate. The product surfaces appear to use this data for targeted services: a telehealth platform connects members within the network, and AI features are applied to administrative tasks like note-taking. The technology stack is not publicly detailed, but current job postings for Data & Analytics and Engineering roles suggest ongoing investment in scaling data infrastructure and machine learning applications (inferred from job postings) [Built In, 2026].
Data Accuracy: YELLOW -- Product claims are sourced from the company website; member metrics are self-reported. Tech stack inferences are drawn from job postings.
Market Research
PUBLIC The market for physician productivity tools is not a new category, but its urgency and scale have been reshaped by a persistent macro pressure: a widening gap between patient demand and clinician supply.
Third-party market sizing for Doximity's specific networking and collaboration niche is not publicly available in the cited sources. However, the company's reported revenue of $570.4 million in fiscal 2025 [Doximity Investors, 2025] provides a direct anchor for its share of a broader market. For context, the U.S. healthcare IT market, which includes administrative and clinical software, was valued at approximately $120 billion in 2024 according to a report from Grand View Research [Grand View Research, 2024]. While this is an analogous market, Doximity's core offerings sit at the intersection of professional networking, telehealth, and clinical workflow software, a segment that likely represents a multi-billion dollar opportunity within that larger figure.
Demand is driven by structural forces within the U.S. healthcare system. Physician burnout and administrative burden are well-documented, creating a consistent pull for tools that streamline communication, documentation, and care coordination. The shift towards value-based care models also incentivizes better provider collaboration and data sharing. Doximity's penetration claim of over 85% of U.S. doctors [Doximity] suggests the platform has become a default utility for addressing these pressures, effectively turning a fragmented professional base into a networked, addressable market.
Key adjacent markets include general telehealth platforms, electronic health record (EHR) systems, and clinical decision support software. These are often substitutes or complements; a physician might use Doximity for peer consults while relying on their hospital's Epic or Cerner system for patient records. The regulatory environment, particularly around data privacy (HIPAA) and telehealth reimbursement, remains a constant macro force. Changes here can either catalyze adoption of secure, compliant platforms like Doximity or introduce compliance overhead that affects product development cycles.
Fiscal 2025 Revenue | 570.4 | $M
U.S. Healthcare IT Market (2024) | 120000 | $M
Doximity's revenue represents a fraction of a percent of the broader healthcare IT market, but its near-saturation of the U.S. physician population indicates it has captured a dominant position in a critical, high-value niche. The gap between these figures underscores both the platform's current monetization of its network and the potential runway if it can expand its service footprint or average revenue per user.
Data Accuracy: YELLOW -- Company revenue is confirmed via SEC filing. Broader market sizing is from a third-party analyst report and is used as an analogous reference point only.
Competitive Landscape
MIXED Doximity's competitive position is defined by its near-saturation of the U.S. physician network, a moat that adjacent platforms and specialized challengers have struggled to replicate.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Doximity | Comprehensive digital hub for U.S. healthcare professionals, combining networking, telehealth, and clinical tools. | Public | Verified network of >85% of U.S. doctors; integrated workflow suite. | [Doximity] |
| Sermo | Global physician network focused on medical insights, market research, and peer-to-peer consultation. | Private | Strong international physician community; emphasis on qualitative insights for pharma and healthcare organizations. | [Crunchbase] |
| Figure 1 | Image-based clinical case sharing and discussion platform for medical professionals. | Private (acquired by ConnectYard in 2021) | Specialization in visual medical case sharing, often described as an "Instagram for doctors." | [Crunchbase] |
| OrthoMinds | Online community and resource platform specifically for orthopedic surgeons. | Private | Hyper-specialization within a single surgical discipline; deep content and networking for a niche audience. | [Crunchbase] |
The competitive map segments into three layers. The broad professional network layer is contested by Sermo, which has built a substantial, albeit more globally focused, physician community. Doximity's dominance in the U.S. is clear, but Sermo represents the primary alternative for multinational life sciences engagement. The second layer consists of feature-specific or specialty-focused platforms like Figure 1 for visual case sharing and OrthoMinds for orthopedics. These serve as partial substitutes, capturing discrete slices of professional engagement that could, in theory, occur on Doximity. The third and most significant layer is the adjacent substitute category: large, general-purpose technology platforms with healthcare ambitions. While not a direct competitor today, the movement of Doximity co-founder Nate Gross to lead healthcare initiatives at OpenAI [Bloomberg, Business Insider, Fortune, 2026] signals a potential future where foundational AI models integrate directly into clinical workflows, bypassing the need for a separate professional network as an intermediary.
Doximity's defensible edge today rests on two pillars: its verified member base and its integrated product suite. The network effect is profound; a platform used by nearly every U.S. doctor for directory services and secure messaging becomes the default channel for professional communication. This is reinforced by the company's expansion into adjacent productivity tools like telehealth and AI-powered documentation, which increase switching costs. The edge is durable so long as Doximity continues to serve the core networking need better than alternatives and maintains its verification standards, which are a key trust signal in a regulated industry. However, this edge is perishable if engagement migrates to more specialized or more deeply integrated platforms. For example, if a major electronic health record (EHR) vendor successfully embedded robust peer collaboration features, it could erode Doximity's position as the central hub.
The company's most significant exposure lies in its reliance on the U.S. market and its potential vulnerability to disintermediation by AI-native clinical tools. While Sermo competes on a global scale, Doximity's international presence is not a highlighted strength. More critically, the integration of advanced AI directly into point-of-care systems,a trend exemplified by OpenAI's healthcare push,could reduce the need for a separate platform for clinical decision support or documentation. Doximity's AI tools would then compete against AI features baked into the EHR, a battle for which distribution is controlled by the EHR vendors themselves.
The most plausible 18-month competitive scenario involves continued consolidation within the professional network layer, with Doximity using its public currency and scale to potentially acquire a feature-specific challenger like Figure 1 to bolster its community engagement. The winner in this scenario is Doximity if it can successfully use its AI and data assets to become an indispensable layer in the clinical workflow stack, not just a communication layer. The loser is the standalone, single-feature platform that fails to expand its value proposition, as clinicians increasingly seek consolidated tools. OrthoMinds, while serving a loyal niche, could see its audience gradually drawn to the broader network and toolset offered by Doximity, especially if Doximity develops deeper specialty-specific communities.
Data Accuracy: YELLOW -- Competitor profiles sourced from Crunchbase; Doximity's positioning from its website. Competitive dynamics and market layer analysis are inferred from available positioning data.
Opportunity
PUBLIC
If Doximity successfully leverages its entrenched network of U.S. physicians, the opportunity lies in becoming the default operating system for clinical workflows, a role that could command a multi-billion dollar valuation anchored in recurring enterprise software spend and data monetization.
The headline opportunity is the evolution from a professional network into the essential clinical productivity layer. The company is not merely a LinkedIn for doctors, but a platform positioned to embed itself into the daily administrative and clinical routines of a captive audience. With over 85% of U.S. doctors as verified members, the platform has achieved a level of penetration that creates a unique distribution channel for any new tool, from telehealth to AI-powered documentation [Doximity]. The outcome is a category-defining platform for healthcare delivery, where Doximity becomes the hub through which care is coordinated, documented, and reimbursed. This is reachable because the company has already demonstrated an ability to layer paid services onto its free network, moving from social features to revenue-generating tools like Dialer and DocBuilder, which suggests a clear path to monetizing deeper workflow integration.
Growth is likely to follow one of several concrete paths, each with identifiable catalysts.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Enterprise SaaS Expansion | Doximity's tools become the mandated clinical communication and telehealth standard for large hospital systems and accountable care organizations (ACOs). | A major multi-state health system signs an enterprise-wide contract for Doximity's suite, including its AI documentation and care coordination modules. | The company's foundation work with over 150 free clinics demonstrates an ability to deploy its tools at an organizational level [Doximity Blog]. Its existing user base within these systems lowers adoption friction. |
| Data & Insights Platform | The company monetizes its aggregated, de-identified data on physician behavior, treatment patterns, and telehealth adoption for life sciences and market research. | Launch of a formalized "Doximity Insights" business unit, with cited partnerships with pharmaceutical or medtech firms. | The platform's curated medical news and engagement patterns generate a unique dataset on physician interests and trends, a model proven by other professional networks. |
| AI-Enabled Workflow Dominance | Doximity's AI documentation and clinical decision-support tools become the industry standard, displacing incumbent electronic health record (EHR) modules for specific tasks. | Strategic partnership or integration with a major EHR vendor (e.g., Epic, Cerner) to embed Doximity's AI tools directly into the physician's workflow. | Co-founder Nate Gross's move to lead healthcare initiatives at OpenAI signals deep expertise in applied AI for medicine, which can be leveraged back into Doximity's product roadmap [Bloomberg, Business Insider, Fortune, 2026]. |
Compounding for Doximity looks like a classic network effect layered with a data moat. Each new physician on the platform increases the value of the network for peer consultation and referral routing. More importantly, deeper engagement with productivity tools generates proprietary data on clinical workflows. This data can be used to train more accurate AI models for documentation or decision-support, which in turn makes the tools more indispensable, driving further adoption and generating even more data. The flywheel is already suggested by the company's product evolution from a directory to a toolset, and by its reported 20% year-over-year revenue growth to $570.4 million, indicating an ability to monetize increasing engagement [Doximity Investors, 2025].
The size of the win, should the enterprise expansion scenario play out, can be framed by looking at comparable vertical SaaS platforms. Companies like Veeva Systems, which provides cloud software for the life sciences industry, trade at significant revenue multiples based on their deep entrenchment in a regulated vertical. While not a direct comparison, it illustrates the valuation potential for a mission-critical software layer in healthcare. If Doximity can transition a material portion of its user base to enterprise contracts, moving beyond individual physician tools to health system-wide deployments, the addressable revenue could scale with the number of covered lives and providers under those contracts. A credible outcome is a company valued as a high-growth healthcare SaaS platform, a scenario that would represent a significant multiple of its current market position (scenario, not a forecast).
Data Accuracy: YELLOW -- The core opportunity thesis relies on company-reported membership metrics and product claims, with partial third-party corroboration of strategic moves (e.g., founder move to OpenAI). The growth scenarios are extrapolated from these foundational facts.
Sources
PUBLIC
[Doximity Investors, 2025] Doximity Investor Relations | https://investors.doximity.com/
[Doximity] About Doximity | https://www.doximity.com/about/company
[Wikipedia] Doximity - Wikipedia | https://en.wikipedia.org/wiki/Doximity
[Grand View Research, 2024] U.S. Healthcare IT Market Size Report | https://www.grandviewresearch.com/industry-analysis/healthcare-it-market
[Crunchbase] Doximity - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/doximity
[Bloomberg, Business Insider, Fortune, 2026] OpenAI Taps Doximity Cofounder to Lead Its Next Healthcare Push | https://www.businessinsider.com/openai-taps-doximity-cofounder-to-lead-its-next-healthcare-push-2025-8
[Built In, 2026] Doximity Careers, Perks + Culture | Built In | https://builtin.com/company/doximity
[Doximity Blog] Introducing Doximity.org | https://people.doximity.com/articles/introducing-doximity-org
Articles about Doximity
- Doximity's Verified Network Convinced 85% of U.S. Doctors to Log In — The professional platform for physicians, now a public company, is betting its clinical collaboration tools can turn daily logins into a $570 million revenue engine.